Hospital Universitário Antonio Pedro   Report issue

Academic/Hospital Phase 3
Founded: Niteroi City Brazil (1951)

Organization Overview

First Clinical Trial
2018
NCT04060771
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hospital Universitário Antonio Pedro

Active Ingredients

Drugs in Phase 3 Trials (2)

dexamethasone (1 trial)

palonosetron (aloxi) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Postoperative Nausea and Vomiting (Phase 3)

Strabismus (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2